| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.25B | 27.02B | 28.84B | 35.30B | 33.27B | 24.87B |
| Gross Profit | 5.16B | 4.86B | 5.29B | 6.93B | 7.10B | 4.39B |
| EBITDA | 730.25M | 514.00M | 485.00M | 2.01B | 2.84B | 749.00M |
| Net Income | -477.00M | -844.00M | -1.29B | 648.00M | 1.28B | -232.00M |
Balance Sheet | ||||||
| Total Assets | 29.99B | 30.10B | 30.06B | 31.90B | 31.13B | 28.57B |
| Cash, Cash Equivalents and Short-Term Investments | 5.04B | 4.83B | 6.17B | 6.50B | 7.14B | 7.18B |
| Total Debt | 4.26B | 3.48B | 2.26B | 1.96B | 1.76B | 960.00M |
| Total Liabilities | 12.89B | 12.44B | 11.48B | 11.92B | 11.51B | 10.42B |
| Stockholders Equity | 16.57B | 17.11B | 18.14B | 19.62B | 19.32B | 17.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.08B | -124.00M | -308.00M | -864.00M | 2.48B |
| Operating Cash Flow | 0.00 | -1.34B | 552.00M | 256.00M | -550.00M | 3.78B |
| Investing Cash Flow | 0.00 | -645.00M | -643.00M | -565.00M | -315.00M | -1.32B |
| Financing Cash Flow | 0.00 | 431.00M | -370.00M | -470.00M | 540.00M | -344.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.04B | 6.26 | ― | 3.41% | -3.27% | 572.42% | |
76 Outperform | ¥13.60B | 11.48 | ― | 0.93% | 23.05% | 89.17% | |
70 Outperform | ¥18.05B | 36.39 | ― | 0.68% | 27.58% | -19.61% | |
64 Neutral | ¥14.43B | 30.21 | ― | 1.17% | 53.68% | 146.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥31.74B | 19.35 | ― | 3.56% | -3.85% | -45.64% | |
57 Neutral | ¥13.64B | -27.62 | ― | 5.43% | 1.46% | 89.88% |